Access to Therapeutics in Northern Ireland in Jeopardy According to Teva

November 25, 2022

A representative for Teva Pharmaceuticals told members of the UK House of Lords that the impending end of a grace period in the North Ireland Protocol portends reduced access to medicines in Northern Ireland. The Protocol allowed the transportation of certain goods, including medications, into the UK without additional customs checks, mirroring the way things were before Brexit.

According to Pharmaphorum, “It was also agreed that Northern Ireland would keep following EU rules on product standards, which is why the province is still largely under the jurisdiction of the EMA, while the MHRA regulates England, Scotland, and Wales.”

To read more, click here.

(Source: Pharmaphorum, November 16th, 2022)

Share This Story!